BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Low LA, Mummery C, Berridge BR, Austin CP, Tagle DA. Organs-on-chips: into the next decade. Nat Rev Drug Discov 2021;20:345-61. [PMID: 32913334 DOI: 10.1038/s41573-020-0079-3] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 30.0] [Reference Citation Analysis]
Number Citing Articles
1 Arjmand B, Kokabi Hamidpour S, Rabbani Z, Tayanloo-beik A, Rahim F, Aghayan HR, Larijani B. Organ on a Chip: A Novel in vitro Biomimetic Strategy in Amyotrophic Lateral Sclerosis (ALS) Modeling. Front Neurol 2022;12:788462. [DOI: 10.3389/fneur.2021.788462] [Reference Citation Analysis]
2 Escribá R, Ferrer-Lorente R, Raya Á. Inborn errors of metabolism: Lessons from iPSC models. Rev Endocr Metab Disord 2021. [PMID: 34241766 DOI: 10.1007/s11154-021-09671-z] [Reference Citation Analysis]
3 Wevers NR, Nair AL, Fowke TM, Pontier M, Kasi DG, Spijkers XM, Hallard C, Rabussier G, van Vught R, Vulto P, de Vries HE, Lanz HL. Modeling ischemic stroke in a triculture neurovascular unit on-a-chip. Fluids Barriers CNS 2021;18:59. [PMID: 34906183 DOI: 10.1186/s12987-021-00294-9] [Reference Citation Analysis]
4 Xu J, Pan D, Liao W, Jia Z, Pan M, Weng J, Han X, Li S, Li Y, Liang K, Zhou S, Peng Q, Gao Y. Application of 3D Hepatic Plate-Like Liver Model for Statin-Induced Hepatotoxicity Evaluation. Front Bioeng Biotechnol 2022;10:826093. [DOI: 10.3389/fbioe.2022.826093] [Reference Citation Analysis]
5 Hammel JH, Zatorski JM, Cook SR, Pompano RR, Munson JM. Engineering in vitro immune-competent tissue models for testing and evaluation of therapeutics. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2022.114111] [Reference Citation Analysis]
6 Ayuso JM, Rehman S, Farooqui M, Virumbrales-Muñoz M, Setaluri V, Skala MC, Beebe DJ. Microfluidic Tumor-on-a-Chip Model to Study Tumor Metabolic Vulnerability. Int J Mol Sci 2020;21:E9075. [PMID: 33260673 DOI: 10.3390/ijms21239075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Langhans SA. Using 3D in vitro cell culture models in anti-cancer drug discovery. Expert Opin Drug Discov 2021;16:841-50. [PMID: 33823728 DOI: 10.1080/17460441.2021.1912731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Besedina NA, Skverchinskaya EA, Ivanov AS, Kotlyar KP, Morozov IA, Filatov NA, Mindukshev IV, Bukatin AS. Microfluidic Characterization of Red Blood Cells Microcirculation under Oxidative Stress. Cells 2021;10:3552. [PMID: 34944060 DOI: 10.3390/cells10123552] [Reference Citation Analysis]
9 Hughes DL, Hughes A, Soonawalla Z, Mukherjee S, O'Neill E. Dynamic Physiological Culture of Ex Vivo Human Tissue: A Systematic Review. Cancers (Basel) 2021;13:2870. [PMID: 34201273 DOI: 10.3390/cancers13122870] [Reference Citation Analysis]
10 Yoon PS, Del Piccolo N, Shirure VS, Peng Y, Kirane A, Canter RJ, Fields RC, George SC, Gholami S. Advances in Modeling the Immune Microenvironment of Colorectal Cancer. Front Immunol 2020;11:614300. [PMID: 33643296 DOI: 10.3389/fimmu.2020.614300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Engelen SE, Robinson AJB, Zurke Y, Monaco C. Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed? Nat Rev Cardiol. [DOI: 10.1038/s41569-021-00668-4] [Reference Citation Analysis]
12 Parreira R, Özelçi E, Sakar MS. Investigating Tissue Mechanics in vitro Using Untethered Soft Robotic Microdevices. Front Robot AI 2021;8:649765. [PMID: 33869296 DOI: 10.3389/frobt.2021.649765] [Reference Citation Analysis]
13 Gough A, Soto-Gutierrez A, Vernetti L, Ebrahimkhani MR, Stern AM, Taylor DL. Human biomimetic liver microphysiology systems in drug development and precision medicine. Nat Rev Gastroenterol Hepatol 2021;18:252-68. [PMID: 33335282 DOI: 10.1038/s41575-020-00386-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
14 Murray BO, Flores C, Williams C, Flusberg DA, Marr EE, Kwiatkowska KM, Charest JL, Isenberg BC, Rohn JL. Recurrent Urinary Tract Infection: A Mystery in Search of Better Model Systems. Front Cell Infect Microbiol 2021;11:691210. [PMID: 34123879 DOI: 10.3389/fcimb.2021.691210] [Reference Citation Analysis]
15 Dornhof J, Kieninger J, Muralidharan H, Maurer J, Urban GA, Weltin A. Microfluidic organ-on-chip system for multi-analyte monitoring of metabolites in 3D cell cultures. Lab Chip 2021. [PMID: 34851349 DOI: 10.1039/d1lc00689d] [Reference Citation Analysis]
16 Lai W, Mu H, Lu Y, Chen H, Wen J, Wu H, Cheng C, Huang J. Dual-cell culture system with identical culture environment for comparison of anti-cancer drug toxicity. Chemical Engineering Science 2022;253:117555. [DOI: 10.1016/j.ces.2022.117555] [Reference Citation Analysis]
17 Trapecar M. Multiorgan microphysiological systems as tools to interrogate interorgan crosstalk and complex diseases. FEBS Lett 2021. [PMID: 34923635 DOI: 10.1002/1873-3468.14260] [Reference Citation Analysis]
18 Shroff T, Aina K, Maass C, Cipriano M, Lambrecht J, Tacke F, Mosig A, Loskill P. Studying metabolism with multi-organ chips: new tools for disease modelling, pharmacokinetics and pharmacodynamics. Open Biol 2022;12:210333. [PMID: 35232251 DOI: 10.1098/rsob.210333] [Reference Citation Analysis]
19 Ho AM, Weinshilboum RM, Frye MA, Biernacka JM. Genetics and antiepileptic mood stabilizer treatment response in bipolar disorder: what do we know? Pharmacogenomics 2021;22:913-25. [PMID: 34486896 DOI: 10.2217/pgs-2021-0041] [Reference Citation Analysis]
20 Williams-Medina A, Deblock M, Janigro D. In vitro Models of the Blood-Brain Barrier: Tools in Translational Medicine. Front Med Technol 2020;2:623950. [PMID: 35047899 DOI: 10.3389/fmedt.2020.623950] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Kiener M, Roldan N, Machahua C, Sengupta A, Geiser T, Guenat OT, Funke-Chambour M, Hobi N, Kruithof-de Julio M. Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19. Front Med (Lausanne) 2021;8:644678. [PMID: 34026781 DOI: 10.3389/fmed.2021.644678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Chi LH, Burrows AD, Anderson RL. Can preclinical drug development help to predict adverse events in clinical trials? Drug Discov Today 2021:S1359-6446(21)00370-6. [PMID: 34469805 DOI: 10.1016/j.drudis.2021.08.010] [Reference Citation Analysis]
23 Ching T, Toh YC, Hashimoto M, Zhang YS. Bridging the academia-to-industry gap: organ-on-a-chip platforms for safety and toxicology assessment. Trends Pharmacol Sci 2021;42:715-28. [PMID: 34187693 DOI: 10.1016/j.tips.2021.05.007] [Reference Citation Analysis]
24 Miller DR, McClain ES, Dodds JN, Balinski A, May JC, McLean JA, Cliffel DE. Chlorpyrifos Disrupts Acetylcholine Metabolism Across Model Blood-Brain Barrier. Front Bioeng Biotechnol 2021;9:622175. [PMID: 34513802 DOI: 10.3389/fbioe.2021.622175] [Reference Citation Analysis]
25 Mastrangeli M, van den Eijnden-van Raaij J. Organs-on-chip: The way forward. Stem Cell Reports 2021:S2213-6711(21)00323-4. [PMID: 34297941 DOI: 10.1016/j.stemcr.2021.06.015] [Reference Citation Analysis]
26 Paggi CA, Teixeira LM, Le Gac S, Karperien M. Joint-on-chip platforms: entering a new era of in vitro models for arthritis. Nat Rev Rheumatol. [DOI: 10.1038/s41584-021-00736-6] [Reference Citation Analysis]
27 Berg EL. The future of phenotypic drug discovery. Cell Chem Biol 2021;28:424-30. [PMID: 33529582 DOI: 10.1016/j.chembiol.2021.01.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Voeltzel T, Fossard G, Degaud M, Geistlich K, Gadot N, Jeanpierre S, Mikaelian I, Brevet M, Anginot A, Le Bousse-Kerdilès MC, Trichet V, Lefort S, Maguer-Satta V. A minimal standardized human bone marrow microphysiological system to assess resident cell behavior during normal and pathological processes. Biomater Sci 2021. [PMID: 34904143 DOI: 10.1039/d1bm01098k] [Reference Citation Analysis]
29 Rivetti di Val Cervo P, Besusso D, Conforti P, Cattaneo E. hiPSCs for predictive modelling of neurodegenerative diseases: dreaming the possible. Nat Rev Neurol 2021;17:381-92. [PMID: 33658662 DOI: 10.1038/s41582-021-00465-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Li J, Chen J, Bai H, Wang H, Hao S, Ding Y, Peng B, Zhang J, Li L, Huang W. An Overview of Organs-on-Chips Based on Deep Learning. Research (Wash D C) 2022;2022:9869518. [PMID: 35136860 DOI: 10.34133/2022/9869518] [Reference Citation Analysis]
31 Hakala TA, Yates EV, Challa PK, Toprakcioglu Z, Nadendla K, Matak-Vinkovic D, Dobson CM, Martínez R, Corzana F, Knowles TPJ, Bernardes GJL. Accelerating Reaction Rates of Biomolecules by Using Shear Stress in Artificial Capillary Systems. J Am Chem Soc 2021;143:16401-10. [PMID: 34606279 DOI: 10.1021/jacs.1c03681] [Reference Citation Analysis]
32 Marx U, Accastelli E, David R, Erfurth H, Koenig L, Lauster R, Ramme AP, Reinke P, Volk HD, Winter A, Dehne EM. An Individual Patient's "Body" on Chips-How Organismoid Theory Can Translate Into Your Personal Precision Therapy Approach. Front Med (Lausanne) 2021;8:728866. [PMID: 34589503 DOI: 10.3389/fmed.2021.728866] [Reference Citation Analysis]
33 Ronaldson-bouchard K, Baldassarri I, Naveed Tavakol D, Graney PL, Samaritano M, Cimetta E, Vunjak-novakovic G. Engineering complexity in human tissue models of cancer. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2022.114181] [Reference Citation Analysis]
34 Kleinstreuer N, Holmes A. Harnessing the power of microphysiological systems for COVID-19 research. Drug Discov Today 2021:S1359-6446(21)00330-5. [PMID: 34332095 DOI: 10.1016/j.drudis.2021.06.020] [Reference Citation Analysis]
35 Foglietta F, Serpe L, Canaparo R. The Effective Combination between 3D Cancer Models and Stimuli-Responsive Nanoscale Drug Delivery Systems. Cells 2021;10:3295. [PMID: 34943803 DOI: 10.3390/cells10123295] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Thomas D, Shenoy S, Sayed N. Building Multi-Dimensional Induced Pluripotent Stem Cells-Based Model Platforms to Assess Cardiotoxicity in Cancer Therapies. Front Pharmacol 2021;12:607364. [PMID: 33679396 DOI: 10.3389/fphar.2021.607364] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 Doherty EL, Aw WY, Hickey AJ, Polacheck WJ. Microfluidic and Organ-on-a-Chip Approaches to Investigate Cellular and Microenvironmental Contributions to Cardiovascular Function and Pathology. Front Bioeng Biotechnol 2021;9:624435. [PMID: 33614613 DOI: 10.3389/fbioe.2021.624435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Özkayar G, Lötters JC, Tichem M, Ghatkesar MK. Toward a modular, integrated, miniaturized, and portable microfluidic flow control architecture for organs-on-chips applications. Biomicrofluidics 2022;16:021302. [DOI: 10.1063/5.0074156] [Reference Citation Analysis]
39 Jayakar S, Shim J, Jo S, Bean BP, Singeç I, Woolf CJ. Developing nociceptor-selective treatments for acute and chronic pain. Sci Transl Med 2021;13:eabj9837. [PMID: 34757806 DOI: 10.1126/scitranslmed.abj9837] [Reference Citation Analysis]
40 Ooka M, Lynch C, Xia M. Application of In Vitro Metabolism Activation in High-Throughput Screening. Int J Mol Sci 2020;21:E8182. [PMID: 33142951 DOI: 10.3390/ijms21218182] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
41 Zhou Z, Zhu J, Jiang M, Sang L, Hao K, He H. The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development. Pharmaceutics 2021;13:704. [PMID: 34065907 DOI: 10.3390/pharmaceutics13050704] [Reference Citation Analysis]
42 Kleiman RJ, Engle SJ. Human inducible pluripotent stem cells: Realization of initial promise in drug discovery. Cell Stem Cell 2021;28:1507-15. [PMID: 34478628 DOI: 10.1016/j.stem.2021.08.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Loskill P, Hardwick RN, Roth A. Challenging the pipeline. Stem Cell Reports 2021;16:2033-7. [PMID: 34525380 DOI: 10.1016/j.stemcr.2021.08.004] [Reference Citation Analysis]
44 Lin K, Yang J, Ho P, Yen C, Huang H, Lin H, Chung J, Chen G. Development of an alveolar chip model to mimic respiratory conditions due to fine particulate matter exposure. Applied Materials Today 2022;26:101281. [DOI: 10.1016/j.apmt.2021.101281] [Reference Citation Analysis]
45 Bennet TJ, Randhawa A, Hua J, Cheung KC. Airway-On-A-Chip: Designs and Applications for Lung Repair and Disease. Cells 2021;10:1602. [PMID: 34206722 DOI: 10.3390/cells10071602] [Reference Citation Analysis]
46 Sun AM, Hoffman T, Luu BQ, Ashammakhi N, Li S. Application of lung microphysiological systems to COVID-19 modeling and drug discovery: a review. Biodes Manuf 2021;:1-19. [PMID: 34178414 DOI: 10.1007/s42242-021-00136-5] [Reference Citation Analysis]
47 Kabay G, Manz A, Dincer C. Microfluidic Roadmap for Translational Nanotheranostics. Small Methods 2021;:e2101217. [PMID: 34957704 DOI: 10.1002/smtd.202101217] [Reference Citation Analysis]
48 Maurissen TL, Pavlou G, Bichsel C, Villaseñor R, Kamm RD, Ragelle H. Microphysiological Neurovascular Barriers to Model the Inner Retinal Microvasculature. JPM 2022;12:148. [DOI: 10.3390/jpm12020148] [Reference Citation Analysis]
49 Rhyou J, Youn J, Eom S, Kim DS. Facile Fabrication of Electrospun Nanofiber Membrane-Integrated PDMS Microfluidic Chip via Silver Nanowires-Uncured PDMS Adhesive Layer. ACS Macro Lett 2021;10:965-70. [DOI: 10.1021/acsmacrolett.1c00256] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Lauffer MC. Organ-on-a-chip technologies to study neuromuscular disorders: possibilities, limitations, and future hopes. Medizinische Genetik 2021;33:261-7. [DOI: 10.1515/medgen-2021-2085] [Reference Citation Analysis]
51 Paterson K, Zanivan S, Glasspool R, Coffelt SB, Zagnoni M. Microfluidic technologies for immunotherapy studies on solid tumours. Lab Chip 2021;21:2306-29. [PMID: 34085677 DOI: 10.1039/d0lc01305f] [Reference Citation Analysis]
52 Boix-Montesinos P, Soriano-Teruel PM, Armiñán A, Orzáez M, Vicent MJ. The past, present, and future of breast cancer models for nanomedicine development. Adv Drug Deliv Rev 2021;173:306-30. [PMID: 33798642 DOI: 10.1016/j.addr.2021.03.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
53 Clement C, Birindelli G, Pizzichemi M, Pagano F, Kruithof-De Julio M, Ziegler S, Rominger A, Auffray E, Shi K. Concept development of an on-chip PET system. EJNMMI Phys 2022;9:38. [PMID: 35588024 DOI: 10.1186/s40658-022-00467-x] [Reference Citation Analysis]
54 Koning JJ, Rodrigues Neves CT, Schimek K, Thon M, Spiekstra SW, Waaijman T, de Gruijl TD, Gibbs S. A Multi-Organ-on-Chip Approach to Investigate How Oral Exposure to Metals Can Cause Systemic Toxicity Leading to Langerhans Cell Activation in Skin. Front Toxicol 2021;3:824825. [PMID: 35295125 DOI: 10.3389/ftox.2021.824825] [Reference Citation Analysis]
55 Zhu Y, Mandal K, Hernandez AL, Kawakita S, Huang W, Bandaru P, Ahadian S, Kim H, Jucaud V, Dokmeci MR, Khademhosseini A. State of the art in integrated biosensors for organ-on-a-chip applications. Current Opinion in Biomedical Engineering 2021;19:100309. [DOI: 10.1016/j.cobme.2021.100309] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
56 Maoz BM. Brain-on-a-Chip: Characterizing the next generation of advanced in vitro platforms for modeling the central nervous system. APL Bioeng 2021;5:030902. [PMID: 34368601 DOI: 10.1063/5.0055812] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
57 Artzy-Schnirman A, Arber Raviv S, Doppelt Flikshtain O, Shklover J, Korin N, Gross A, Mizrahi B, Schroeder A, Sznitman J. Advanced human-relevant in vitro pulmonary platforms for respiratory therapeutics. Adv Drug Deliv Rev 2021;:113901. [PMID: 34331989 DOI: 10.1016/j.addr.2021.113901] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
58 Hwang SH, Lee S, Park JY, Jeon JS, Cho YJ, Kim S. Potential of Drug Efficacy Evaluation in Lung and Kidney Cancer Models Using Organ-on-a-Chip Technology. Micromachines (Basel) 2021;12:215. [PMID: 33669950 DOI: 10.3390/mi12020215] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Young RE, Huh DD. Organ-on-a-chip technology for the study of the female reproductive system. Adv Drug Deliv Rev 2021;173:461-78. [PMID: 33831478 DOI: 10.1016/j.addr.2021.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Mak KK, Epemolu O, Pichika MR. The role of DMPK science in improving pharmaceutical research and development efficiency. Drug Discov Today 2021:S1359-6446(21)00484-0. [PMID: 34774767 DOI: 10.1016/j.drudis.2021.11.005] [Reference Citation Analysis]
61 Liu Y, Sun L, Zhang H, Shang L, Zhao Y. Microfluidics for Drug Development: From Synthesis to Evaluation. Chem Rev 2021;121:7468-529. [PMID: 34024093 DOI: 10.1021/acs.chemrev.0c01289] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
62 Zou Z, Luo X, Chen Z, Zhang YS, Wen C. Emerging microfluidics-enabled platforms for osteoarthritis management: from benchtop to bedside. Theranostics 2022;12:891-909. [PMID: 34976219 DOI: 10.7150/thno.62685] [Reference Citation Analysis]
63 Lee Y, Kim MH, Alves DR, Kim S, Lee LP, Sung JH, Park S. Gut-Kidney Axis on Chip for Studying Effects of Antibiotics on Risk of Hemolytic Uremic Syndrome by Shiga Toxin-Producing Escherichia coli. Toxins (Basel) 2021;13:775. [PMID: 34822559 DOI: 10.3390/toxins13110775] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Rimsa R, Galvanovskis A, Plume J, Rumnieks F, Grindulis K, Paidere G, Erentraute S, Mozolevskis G, Abols A. Lung on a Chip Development from Off-Stoichiometry Thiol-Ene Polymer. Micromachines (Basel) 2021;12:546. [PMID: 34064627 DOI: 10.3390/mi12050546] [Reference Citation Analysis]
65 Lei L, Ma B, Xu C, Liu H. Emerging Tumor-on-Chips with Electrochemical Biosensors. TrAC Trends in Analytical Chemistry 2022. [DOI: 10.1016/j.trac.2022.116640] [Reference Citation Analysis]
66 Viñas R, Azevedo T, Gamazon ER, Liò P. Deep Learning Enables Fast and Accurate Imputation of Gene Expression. Front Genet 2021;12:624128. [PMID: 33927746 DOI: 10.3389/fgene.2021.624128] [Reference Citation Analysis]
67 Milojević M, Rožanc J, Vajda J, Činč Ćurić L, Paradiž E, Stožer A, Maver U, Vihar B. In Vitro Disease Models of the Endocrine Pancreas. Biomedicines 2021;9:1415. [PMID: 34680532 DOI: 10.3390/biomedicines9101415] [Reference Citation Analysis]
68 Quader S, Kataoka K, Cabral H. Nanomedicine for Brain Cancer. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2022.114115] [Reference Citation Analysis]
69 Saydmohammed M, Jha A, Mahajan V, Gavlock D, Shun TY, DeBiasio R, Lefever D, Li X, Reese C, Kershaw EE, Yechoor V, Behari J, Soto-Gutierrez A, Vernetti L, Stern A, Gough A, Miedel MT, Lansing Taylor D. Quantifying the progression of non-alcoholic fatty liver disease in human biomimetic liver microphysiology systems with fluorescent protein biosensors. Exp Biol Med (Maywood) 2021;:15353702211009228. [PMID: 33957803 DOI: 10.1177/15353702211009228] [Reference Citation Analysis]
70 du Chatinier DN, Figler KP, Agrawal P, Liu W, Zhang YS. The potential of microfluidics-enhanced extrusion bioprinting. Biomicrofluidics 2021;15:041304. [PMID: 34367403 DOI: 10.1063/5.0033280] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Goldstein Y, Spitz S, Turjeman K, Selinger F, Barenholz Y, Ertl P, Benny O, Bavli D. Breaking the Third Wall: Implementing 3D-Printing Technics to Expand the Complexity and Abilities of Multi-Organ-on-a-Chip Devices. Micromachines (Basel) 2021;12:627. [PMID: 34071476 DOI: 10.3390/mi12060627] [Reference Citation Analysis]
72 Cai B, Gong Y, Wang Z, Wang L, Chen W. Microneedle arrays integrated with living organisms for smart biomedical applications. Theranostics 2021;11:10012-29. [PMID: 34815801 DOI: 10.7150/thno.66478] [Reference Citation Analysis]
73 Nitsche KS, Müller I, Malcomber S, Carmichael PL, Bouwmeester H. Implementing organ-on-chip in a next-generation risk assessment of chemicals: a review. Arch Toxicol 2022. [PMID: 35103818 DOI: 10.1007/s00204-022-03234-0] [Reference Citation Analysis]
74 Palacio-Castañeda V, Oude Egberink R, Sait A, Andrée L, Sala BM, Hassani Besheli N, Oosterwijk E, Nilvebrant J, Leeuwenburgh SCG, Brock R, Verdurmen WPR. Mimicking the Biology of Engineered Protein and mRNA Nanoparticle Delivery Using a Versatile Microfluidic Platform. Pharmaceutics 2021;13:1944. [PMID: 34834361 DOI: 10.3390/pharmaceutics13111944] [Reference Citation Analysis]
75 Battat S, Weitz DA, Whitesides GM. An outlook on microfluidics: the promise and the challenge. Lab Chip 2022. [PMID: 35048918 DOI: 10.1039/d1lc00731a] [Reference Citation Analysis]
76 Lucchetti M, Kaminska M, Oluwasegun AK, Mosig AS, Wilmes P. Emulating the gut-liver axis: Dissecting the microbiome's effect on drug metabolism using multiorgan-on-chip models. Curr Opin Endocr Metab Res 2021;18:94-101. [PMID: 34239997 DOI: 10.1016/j.coemr.2021.03.003] [Reference Citation Analysis]
77 Jung O, Song MJ, Ferrer M. Operationalizing the Use of Biofabricated Tissue Models as Preclinical Screening Platforms for Drug Discovery and Development. SLAS Discov 2021;:24725552211030903. [PMID: 34269079 DOI: 10.1177/24725552211030903] [Reference Citation Analysis]
78 Jiang Y, Torun T, Maffioletti SM, Serio A, Tedesco FS. Bioengineering human skeletal muscle models: Recent advances, current challenges and future perspectives. Experimental Cell Research 2022. [DOI: 10.1016/j.yexcr.2022.113133] [Reference Citation Analysis]
79 Singh AV, Romeo A, Scott K, Wagener S, Leibrock L, Laux P, Luch A, Kerkar P, Balakrishnan S, Dakua SP, Park BW. Emerging Technologies for In Vitro Inhalation Toxicology. Adv Healthc Mater 2021;:e2100633. [PMID: 34292676 DOI: 10.1002/adhm.202100633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
80 Kitano H. Nobel Turing Challenge: creating the engine for scientific discovery. NPJ Syst Biol Appl 2021;7:29. [PMID: 34145287 DOI: 10.1038/s41540-021-00189-3] [Reference Citation Analysis]
81 Claridge B, Lozano J, Poh QH, Greening DW. Development of Extracellular Vesicle Therapeutics: Challenges, Considerations, and Opportunities. Front Cell Dev Biol 2021;9:734720. [PMID: 34616741 DOI: 10.3389/fcell.2021.734720] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
82 Kang S, Park SE, Huh DD. Organ-on-a-chip technology for nanoparticle research. Nano Converg 2021;8:20. [PMID: 34236537 DOI: 10.1186/s40580-021-00270-x] [Reference Citation Analysis]
83 Bayir Garbioglu D, Demir N, Ozel C, Avci H, Dincer M. Determination of therapeutic agents efficiencies of microsatellite instability high colon cancer cells in post-metastatic liver biochip modeling. FASEB J 2021;35:e21834. [PMID: 34403553 DOI: 10.1096/fj.202100333R] [Reference Citation Analysis]
84 Kanabekova P, Kadyrova A, Kulsharova G. Microfluidic Organ-on-a-Chip Devices for Liver Disease Modeling In Vitro. Micromachines 2022;13:428. [DOI: 10.3390/mi13030428] [Reference Citation Analysis]
85 Mahadeo A, Yeung CK, Himmelfarb J, Kelly EJ. Kidney microphysiological models for nephrotoxicity assessment. Current Opinion in Toxicology 2022. [DOI: 10.1016/j.cotox.2022.03.002] [Reference Citation Analysis]
86 Herrlich A, Kefaloyianni E, Rose-John S. Mechanisms of interorgan crosstalk in health and disease. FEBS Lett 2022;596:529-33. [PMID: 35288939 DOI: 10.1002/1873-3468.14313] [Reference Citation Analysis]
87 Shanti A, Hallfors N, Petroianu GA, Planelles L, Stefanini C. Lymph Nodes-On-Chip: Promising Immune Platforms for Pharmacological and Toxicological Applications. Front Pharmacol 2021;12:711307. [PMID: 34483920 DOI: 10.3389/fphar.2021.711307] [Reference Citation Analysis]
88 Li M, Gong J, Gao L, Zou T, Kang J, Xu H. Advanced human developmental toxicity and teratogenicity assessment using human organoid models. Ecotoxicol Environ Saf 2022;235:113429. [PMID: 35325609 DOI: 10.1016/j.ecoenv.2022.113429] [Reference Citation Analysis]
89 Graney PL, Tavakol DN, Chramiec A, Ronaldson-Bouchard K, Vunjak-Novakovic G. Engineered models of tumor metastasis with immune cell contributions. iScience 2021;24:102179. [PMID: 33718831 DOI: 10.1016/j.isci.2021.102179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
90 Sharma A, Clemens RA, Garcia O, Taylor DL, Wagner NL, Shepard KA, Gupta A, Malany S, Grodzinsky AJ, Kearns-Jonker M, Mair DB, Kim DH, Roberts MS, Loring JF, Hu J, Warren LE, Eenmaa S, Bozada J, Paljug E, Roth M, Taylor DP, Rodrigue G, Cantini P, Smith AW, Giulianotti MA, Wagner WR. Biomanufacturing in low Earth orbit for regenerative medicine. Stem Cell Reports 2021:S2213-6711(21)00598-1. [PMID: 34971562 DOI: 10.1016/j.stemcr.2021.12.001] [Reference Citation Analysis]
91 Kasi DG, de Graaf MNS, Motreuil-Ragot PA, Frimat JMS, Ferrari MD, Sarro PM, Mastrangeli M, van den Maagdenberg AMJM, Mummery CL, Orlova VV. Rapid Prototyping of Organ-on-a-Chip Devices Using Maskless Photolithography. Micromachines (Basel) 2021;13:49. [PMID: 35056214 DOI: 10.3390/mi13010049] [Reference Citation Analysis]
92 Donoghue L, Nguyen KT, Graham C, Sethu P. Tissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing. Micromachines (Basel) 2021;12:139. [PMID: 33525451 DOI: 10.3390/mi12020139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 King J, Swapnasrita S, Truckenmüller R, Giselbrecht S, Masereeuw R, Carlier A. Modeling indoxyl sulfate transport in a bioartificial kidney: Two-step binding kinetics or lumped parameters model for uremic toxin clearance? Comput Biol Med 2021;138:104912. [PMID: 34628208 DOI: 10.1016/j.compbiomed.2021.104912] [Reference Citation Analysis]
94 Achberger K, Cipriano M, Düchs MJ, Schön C, Michelfelder S, Stierstorfer B, Lamla T, Kauschke SG, Chuchuy J, Roosz J, Mesch L, Cora V, Pars S, Pashkovskaia N, Corti S, Hartmann SM, Kleger A, Kreuz S, Maier U, Liebau S, Loskill P. Human stem cell-based retina on chip as new translational model for validation of AAV retinal gene therapy vectors. Stem Cell Reports 2021;16:2242-56. [PMID: 34525384 DOI: 10.1016/j.stemcr.2021.08.008] [Reference Citation Analysis]
95 Harb A, Fakhreddine M, Zaraket H, Saleh FA. Three-Dimensional Cell Culture Models to Study Respiratory Virus Infections Including COVID-19. Biomimetics (Basel) 2021;7:3. [PMID: 35076456 DOI: 10.3390/biomimetics7010003] [Reference Citation Analysis]
96 Nguyen J, Lin YY, Gerecht S. The next generation of endothelial differentiation: Tissue-specific ECs. Cell Stem Cell 2021;28:1188-204. [PMID: 34081899 DOI: 10.1016/j.stem.2021.05.002] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
97 Garcia-Gutierrez E, Cotter PD. Relevance of organ(s)-on-a-chip systems to the investigation of food-gut microbiota-host interactions. Crit Rev Microbiol 2021;:1-26. [PMID: 34591726 DOI: 10.1080/1040841X.2021.1979933] [Reference Citation Analysis]
98 Colombo E, Cattaneo MG. Multicellular 3D Models to Study Tumour-Stroma Interactions. Int J Mol Sci 2021;22:1633. [PMID: 33562840 DOI: 10.3390/ijms22041633] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
99 Yoo G, Park D, Kim Y, Chung C. New Insights into the Clinical Implications of Yes-Associated Protein in Lung Cancer: Roles in Drug Resistance, Tumor Immunity, Autophagy, and Organoid Development. Cancers (Basel) 2021;13:3069. [PMID: 34202980 DOI: 10.3390/cancers13123069] [Reference Citation Analysis]
100 Ronaldson-Bouchard K, Teles D, Yeager K, Tavakol DN, Zhao Y, Chramiec A, Tagore S, Summers M, Stylianos S, Tamargo M, Lee BM, Halligan SP, Abaci EH, Guo Z, Jacków J, Pappalardo A, Shih J, Soni RK, Sonar S, German C, Christiano AM, Califano A, Hirschi KK, Chen CS, Przekwas A, Vunjak-Novakovic G. A multi-organ chip with matured tissue niches linked by vascular flow. Nat Biomed Eng 2022;6:351-71. [PMID: 35478225 DOI: 10.1038/s41551-022-00882-6] [Reference Citation Analysis]
101 Tavakol DN, Fleischer S, Vunjak-Novakovic G. Harnessing organs-on-a-chip to model tissue regeneration. Cell Stem Cell 2021;28:993-1015. [PMID: 34087161 DOI: 10.1016/j.stem.2021.05.008] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
102 Faustino D, Brinkmeier H, Logotheti S, Jonitz-Heincke A, Yilmaz H, Takan I, Peters K, Bader R, Lang H, Pavlopoulou A, Pützer BM, Spitschak A. Novel integrated workflow allows production and in-depth quality assessment of multifactorial reprogrammed skeletal muscle cells from human stem cells. Cell Mol Life Sci 2022;79:229. [PMID: 35396689 DOI: 10.1007/s00018-022-04264-8] [Reference Citation Analysis]
103 Burton GJ, Turco MY. Joan Hunt Senior award lecture: New tools to shed light on the 'black box' of pregnancy. Placenta 2021:S0143-4004(21)00666-4. [PMID: 34952691 DOI: 10.1016/j.placenta.2021.12.017] [Reference Citation Analysis]
104 Ewald ML, Chen YH, Lee AP, Hughes CCW. The vascular niche in next generation microphysiological systems. Lab Chip 2021;21:3244-62. [PMID: 34396383 DOI: 10.1039/d1lc00530h] [Reference Citation Analysis]
105 Kim AG, Kim TW, Kwon WK, Lee KH, Jeong S, Hwang MH, Choi H. Microfluidic Chip with Low Constant-Current Stimulation (LCCS) Platform: Human Nucleus Pulposus Degeneration In Vitro Model for Symptomatic Intervertebral Disc. Micromachines (Basel) 2021;12:1291. [PMID: 34832700 DOI: 10.3390/mi12111291] [Reference Citation Analysis]
106 Kumar V, Madhurakkat Perikamana SK, Tata A, Hoque J, Gilpin A, Tata PR, Varghese S. An In Vitro Microfluidic Alveolus Model to Study Lung Biomechanics. Front Bioeng Biotechnol 2022;10:848699. [DOI: 10.3389/fbioe.2022.848699] [Reference Citation Analysis]
107 Neves ER, Harley BAC, Pedron S. Microphysiological systems to study tumor-stroma interactions in brain cancer. Brain Res Bull 2021;174:220-9. [PMID: 34166771 DOI: 10.1016/j.brainresbull.2021.06.012] [Reference Citation Analysis]
108 Treherne JM, Langley GR. Converging global crises are forcing the rapid adoption of disruptive changes in drug discovery. Drug Discov Today 2021:S1359-6446(21)00234-8. [PMID: 34015541 DOI: 10.1016/j.drudis.2021.05.001] [Reference Citation Analysis]
109 Luxen M, van Meurs M, Molema G. Unlocking the Untapped Potential of Endothelial Kinase and Phosphatase Involvement in Sepsis for Drug Treatment Design. Front Immunol 2022;13:867625. [DOI: 10.3389/fimmu.2022.867625] [Reference Citation Analysis]
110 Marei I, Abu Samaan T, Al-quradaghi MA, Farah AA, Mahmud SH, Ding H, Triggle CR. 3D Tissue-Engineered Vascular Drug Screening Platforms: Promise and Considerations. Front Cardiovasc Med 2022;9:847554. [DOI: 10.3389/fcvm.2022.847554] [Reference Citation Analysis]
111 Gholizadeh H, Cheng S, Kourmatzis A, Xing H, Traini D, Young PM, Ong HX. Application of Micro-Engineered Kidney, Liver, and Respiratory System Models to Accelerate Preclinical Drug Testing and Development. Bioengineering 2022;9:150. [DOI: 10.3390/bioengineering9040150] [Reference Citation Analysis]
112 Hargrove-Grimes P, Low LA, Tagle DA. Microphysiological systems: What it takes for community adoption. Exp Biol Med (Maywood) 2021;246:1435-46. [PMID: 33899539 DOI: 10.1177/15353702211008872] [Reference Citation Analysis]
113 Mathieu D, Stéphane P, Benedikt S, Rachid J, Yannick T, Marjorie L, Johanna B, Francoise G, Bertrand G, Hiroshi A, Yukio K, Soo Hyeon K, Taketomo K, Atsushi M, Yasuyuki S, Eric L. Influence of CPM-dependent sorting on the multi-omics profile of hepatocyte-like cells matured in microscale biochips. Biochemical Engineering Journal 2022;181:108408. [DOI: 10.1016/j.bej.2022.108408] [Reference Citation Analysis]
114 Kolarzyk AM, Lee E. A lymphatic co-culture model for personalized cancer medicine. EBioMedicine 2021;73:103685. [PMID: 34753105 DOI: 10.1016/j.ebiom.2021.103685] [Reference Citation Analysis]
115 Marconi GD, Porcheri C, Trubiani O, Mitsiadis TA. Three-Dimensional Culture Systems for Dissecting Notch Signalling in Health and Disease. Int J Mol Sci 2021;22:12473. [PMID: 34830355 DOI: 10.3390/ijms222212473] [Reference Citation Analysis]
116 Ahmadi F, Quach ABV, Shih SCC. Is microfluidics the "assembly line" for CRISPR-Cas9 gene-editing? Biomicrofluidics 2020;14:061301. [PMID: 33262863 DOI: 10.1063/5.0029846] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
117 Vazquez M. Microfluidic and Microscale Assays to Examine Regenerative Strategies in the Neuro Retina. Micromachines (Basel) 2020;11:E1089. [PMID: 33316971 DOI: 10.3390/mi11121089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
118 G. Valverde M, Faria J, Sendino Garví E, Janssen MJ, Masereeuw R, Mihăilă SM. Organs-on-chip technology: a tool to tackle genetic kidney diseases. Pediatr Nephrol. [DOI: 10.1007/s00467-022-05508-2] [Reference Citation Analysis]
119 Imran M, Jha SK, Hasan N, Insaf A, Shrestha J, Shrestha J, Devkota HP, Khan S, Panth N, Warkiani ME, Dua K, Hansbro PM, Paudel KR, Mohammed Y. Overcoming Multidrug Resistance of Antibiotics via Nanodelivery Systems. Pharmaceutics 2022;14:586. [DOI: 10.3390/pharmaceutics14030586] [Reference Citation Analysis]
120 Patel SN, Mathews CE, Chandler R, Stabler CL. The Foundation for Engineering a Pancreatic Islet Niche. Front Endocrinol 2022;13:881525. [DOI: 10.3389/fendo.2022.881525] [Reference Citation Analysis]
121 Yang Q, Wijerathne H, Langston JC, Kiani MF, Kilpatrick LE. Emerging Approaches to Understanding Microvascular Endothelial Heterogeneity: A Roadmap for Developing Anti-Inflammatory Therapeutics. Int J Mol Sci 2021;22:7770. [PMID: 34360536 DOI: 10.3390/ijms22157770] [Reference Citation Analysis]
122 Imparato G, Urciuolo F, Netti PA. Organ on Chip Technology to Model Cancer Growth and Metastasis. Bioengineering (Basel) 2022;9:28. [PMID: 35049737 DOI: 10.3390/bioengineering9010028] [Reference Citation Analysis]
123 Wang H, Brown PC, Chow ECY, Ewart L, Ferguson SS, Fitzpatrick S, Freedman BS, Guo GL, Hedrich W, Heyward S, Hickman J, Isoherranen N, Li AP, Liu Q, Mumenthaler SM, Polli J, Proctor WR, Ribeiro A, Wang JY, Wange RL, Huang SM. 3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration. Clin Transl Sci 2021. [PMID: 33982436 DOI: 10.1111/cts.13066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
124 Tajeddin A, Mustafaoglu N. Design and Fabrication of Organ-on-Chips: Promises and Challenges. Micromachines (Basel) 2021;12:1443. [PMID: 34945293 DOI: 10.3390/mi12121443] [Reference Citation Analysis]
125 Tavakol DN, Fleischer S, Falcucci T, Graney PL, Halligan SP, Kaplan DL, Vunjak-Novakovic G. Emerging Trajectories for Next Generation Tissue Engineers. ACS Biomater Sci Eng 2021. [PMID: 34878769 DOI: 10.1021/acsbiomaterials.1c01428] [Reference Citation Analysis]
126 Zhang Y, Yang N, Xie L, Shu F, Shi Q, Shaheen N. A New 3D Cultured Liver Chip and Real-Time Monitoring System Based on Microfluidic Technology. Micromachines (Basel) 2020;11:E1118. [PMID: 33339350 DOI: 10.3390/mi11121118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
127 Nair AL, Mesch L, Schulz I, Becker H, Raible J, Kiessling H, Werner S, Rothbauer U, Schmees C, Busche M, Trennheuser S, Fricker G, Stelzle M. Parallelizable Microfluidic Platform to Model and Assess In Vitro Cellular Barriers: Technology and Application to Study the Interaction of 3D Tumor Spheroids with Cellular Barriers. Biosensors (Basel) 2021;11:314. [PMID: 34562904 DOI: 10.3390/bios11090314] [Reference Citation Analysis]
128 Speciale AA, Ellerington R, Goedert T, Rinaldi C. Modelling Neuromuscular Diseases in the Age of Precision Medicine. J Pers Med 2020;10:E178. [PMID: 33080928 DOI: 10.3390/jpm10040178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
129 Cecen B, Karavasili C, Nazir M, Bhusal A, Dogan E, Shahriyari F, Tamburaci S, Buyukoz M, Kozaci LD, Miri AK. Multi-Organs-on-Chips for Testing Small-Molecule Drugs: Challenges and Perspectives. Pharmaceutics 2021;13:1657. [PMID: 34683950 DOI: 10.3390/pharmaceutics13101657] [Reference Citation Analysis]